GENE ONLINE|News &
Opinion
Blog

Vertex Pharmaceuticals
Deals AcquisitionsVertex Pharmaceuticals
Vertex Pharmaceuticals Makes $4.9 Billion Bet on Kidney Disease Treatment through Alpine Immune Acquisition
2024-04-11
Trials & Approvals CRISPR Genome Editing
Groundbreaking CRISPR/Cas9-based Genome Editing Therapy Secured the Second FDA Approval
2024-01-18
Trials & Approvals CRISPR-CAS9
FDA Approves A CRISPR-Based Therapy for Sickle Cell Disease
2023-12-12
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Partnerships diabetes treatmentVertex Pharmaceuticals
Vertex and Lonza Collaborate to Revolutionize Type 1 Diabetes Treatment
2023-06-29
Licensing
Vertex and CRISPR Collaborate Again with $330 Million Diabetes Gene Editing Deal
2023-03-28
Vertex’s Orkambi Racks Up Another Approval For Cystic Fibrosis
2022-09-05
Partnerships Liver Disease
Verve and Vertex Agree to Co-Develop In Vivo Gene Editing Program for Liver Disease
2022-07-21
Licensing CRISPR
Vertex Signs $700 Million worth CRISPR Pact with Jennifer Doudna Co-founded Gene Editing Firm
2021-10-26
Licensing Cell and Gene Therapy
Vertex Inks $1.2B Pact with Feng Zhang Cofounded Startup to Develop Gene Therapies for Blood Diseases
2021-08-25
Technology CRISPR
Vertex to Reap Majority Profits from Gene Editing Deal with CRISPR Therapeutics
2021-04-21
Trials & Approvals Cystic Fibrosis
FDA Approves 3 Cystic Fibrosis Drugs of Vertex for Patients with Rare Mutations
2020-12-24
Technology CRISPR
CRISPR Therapeutics Scores Prestigious Grant for Advancing Gene Therapies for HIV
2020-12-16
Technology
CRISPR Gene-Edited Therapy CTX001 Raises Hopes for Sickle Cell Disease and β-Thalassemia Cures
2020-12-07
Trials & Approvals Cystic Fibrosis
Vertex Bags EU Approval for Cystic Fibrosis Treatment in Children Aged 6-11 Years
2020-11-29
1 2
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top